Eli Lilly, manufacturer of weight-loss drugs Mounjaro and Foundayo, sponsored Vogue World in Milan and the 2025 Hollywood edition, sparking criticism from eating disorder charities and academics who warn the partnership conflates fashion's promotion of thinness with medical weight-loss interventions. Experts expressed concern that positioning body modification as an aspirational lifestyle choice normalizes unhealthy appearance pressures, particularly for vulnerable audiences already influenced by the fashion industry's idealization of extreme thinness.